Cargando…
Thiopurine use associated with reduced B and natural killer cells in inflammatory bowel disease
AIM: To identify which blood and mucosal lymphocyte populations are specifically depleted by thiopurine use in vivo. METHODS: The thiopurines azathioprine and 6-mercaptopurine have been a mainstay of inflammatory bowel disease (IBD) therapy for decades, but their mechanism of action in vivo remains...
Autores principales: | Lord, James D, Shows, Donna M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434429/ https://www.ncbi.nlm.nih.gov/pubmed/28566883 http://dx.doi.org/10.3748/wjg.v23.i18.3240 |
Ejemplares similares
-
Thiopurine Methyltransferase Activity and Thiopurine Metabolites in Inflammatory Bowel Disease
por: El-Matary, Wael
Publicado: (2020) -
Thiopurines in Inflammatory Bowel Disease. How to Optimize Thiopurines in the Biologic Era?
por: Gargallo-Puyuelo, Carla J., et al.
Publicado: (2021) -
Use of thiopurines in inflammatory bowel disease: an update
por: Singh, Arshdeep, et al.
Publicado: (2022) -
Thiopurine methyltransferase genotype and thiopurine S-methyltransferase activity in Greek children with inflammatory bowel disease
por: Gazouli, Μaria, et al.
Publicado: (2012) -
Influence of NUDT15 variants on hematological pictures of patients with inflammatory bowel disease treated with thiopurines
por: Kojima, Yuichiro, et al.
Publicado: (2018)